...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: RVXOT
3
May 05, 2020 06:31PM
2
May 05, 2020 09:01PM
1
May 06, 2020 09:21AM
1
May 06, 2020 11:02AM
1
May 06, 2020 11:13AM
1
May 06, 2020 11:59AM

Makes you wonder wether they are trying to confuse investors.This looks like a "Shell" company to me

1
May 06, 2020 02:32PM
Share
New Message
Please login to post a reply